The role of H2-receptor antagonists in the pathogenesis of nosocomial pneumonia in mechanically ventilated patients

Pharmacotherapy

Volumn 18, Issue 4, 1998, Pages 808-815

  Trofe, Jennifer ^a   Peterson, Andrew M ^a  

^a UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; PLACEBO; RANITIDINE; SUCRALFATE;

ADULT; AGED; ALKALINIZATION; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; CRITICAL ILLNESS; DRUG INDUCED DISEASE; FEMALE; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PATHOGENESIS; PNEUMONIA; PROPHYLAXIS; REVIEW; STRESS ULCER; CROSS INFECTION;

CROSS INFECTION; HISTAMINE H2 ANTAGONISTS; HUMANS; META-ANALYSIS; PNEUMONIA; RESPIRATION, ARTIFICIAL;

EID: 0031595715     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy and preventive strategies: a consensus statement. Am J Respir Crit Care Med 1995;153:1711-25.
2. Craven DE, Steger KA, Barber TW. Preventing nosocomial pneumonia: state of the art and perspective for the 1990s. Am J Med 1991;91(S38):44S-52.
3. Donowitz LG, Page MC, Mileur BL, Guenther SH. Alteration of normal gastric flora in critical care patients receiving antacid and cimetidine therapy. Infect Control 1986;7:23-6.
4. Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 1994;330:377-81.
5. Driks MR, Craven CE, Celli BR, Manning M, Burke RA, Garvin GM. Nosocomial pneumonia in intubated patients randomized to sucralfate versus antacids and/or histamine type 2 blockers. N Engl J Med 1987;317:1376-82.
6. Anonymous. Guidelines for prevention of nosocomial pneumonia. MMWR 1997;RR-1:46.
7. Prod'hom G, Levenberger P, Koerfer J, et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer: a randomized controlled trial. Ann Intern Med 1994;120: 653-62.
8. Apte NM, Dilip RK, Medhekar TP, Tilve GH, Morye S, Bhave GG. Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: a randomized, controlled trial. Crit Care Med 1992;20:590-3.
9. Inglis TJJ, Sherratt MJ, Sproat LJ, Gibson JS, Hawkey PM. Gastroduodenal dysfunction and bacterial colonisation of the ventilated lung. Lancet 1993;341:911-13.
10. Kappstein I, Schulgen G, Friedrich T, et al. Incidence of pneumonia in mechanically ventilate patients treated with sucralfate or cimetidine as prophylaxis for stress bleeding: bacterial colonization of the stomach. Am J Med 1991;91(2A): 125S-31.
11. Eddleston JM, Vohra A, Scott P, et al. A comparison of the frequency of stress ulceration and secondary pneumonia in sucralfate-or ranitidine-treated intensive care unit patients. Crit Care Med 1991;19:1491-6.
12. Simms HH, DeMaria E, McDonald L, Peterson D, Robinson A, Burchard KW. Role of gastric colonization in the development of pneumonia in critically ill trauma patients: results of a prospective, randomized trial. J Trauma 1991;31:531-7.
13. Fabian TC, Boucher BA, Croce MA, et al. Pneumonia and stress ulceraion in severely injured patients: a prospective evaluation of the effects of stress ulcer prophylaxis. Arch Surg 1993;128:185-92.
14. Thomason MH, Payseur ES, Hakenwerth AM, et al. Nosocomial pneumonia in ventilated trauma patients during stress ulcer prophylaxis with sucralfate, antacid and ranitidine. J Trauma 1996;41:503-8.
15. Martin LF, Booth FVM, Karlstadt RG, et al. Continuous intravenous cimetidine decreases stress-related upper gastrointestinal hemorrhage without promoting pneumonia. Crit Care Med 1993;21:19-30.
16. Karlstadt R, Herson J, Palmer R, Frank W, Young M. Cimetidine reduces upper GI bleeding and nosocomial pneumonia in ICU patients [abstr]. Am J Gastroenterol 1989;84:1162.
17. Reusser P, Zimmerli W, Scheidegger D, Marbert GA, Buser M, Gyr K. Role of gastric colonization in nosocomial infections and endotoxemia: a prospective study in neuro-surgical patients on mechanical ventilation. J Infect Dis 1989;160:414-21.
18. Holzapfel L, Daveau L, Coupry A, et al. Prophylaxis against stress induced bleeding and nosocomial pneumonia in patients on mechanical ventilation. Intensive Care Med 1990;16(suppl 1):S4.
19. Garcia-Labattut A, Rodriguez-Munoz S, Gobernado-Serrano M, et al. Sucralfate versus cimetidine in the stress bleeding prophylaxis [abstr]. Intensive Care Med 1990;16(suppl):569.
20. Pickworth KK, Falcone RE, Hoogeboom JE, Santanella SA. Occurrence of nosocomial pneumonias in mechanically ventilated trauma patients: a comparison of sucralfate and ranitidine. Crit Care Med 1993;21:1856-62.
21. Ryan P, Dawson J, Teres D, Celoria G, Nauab F. Nosocomial pneumonia during stress ulcer prophylaxis with cimetidine and sucralfate. Arch Surg 1993;128:1353-7.
22. Menachem-Ben T, Fogel R, Patel RV, et al. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit: a randomized, controlled, single-blind study. Ann Intern Med 1994;121:568-75.
23. Laggner AN, Lenz K, Base W, Druml W, Schneeweiss B, Grimm G. Prevention of upper gastrointestinal bleeding in long term ventilated patients. Am J Med 1989;86(suppl 6A):81-4.
24. Salata RA, Lederman MM, Shlaes DM, et al. Diagnosis of nosocomial pneumonia in intubated intensive care unit patients. Am Rev Respir Dis 1987;135:426-32.
25. D'Agostino RB, Weintraub M. Meta-analysis: a method for synthesizing research. Clin Pharmacol Ther 1995;58:605-16.
26. 2-antagonists for stress ulcer prophylaxis: a meta-analysis on efficacy and pneumonia rate. Crit Care Med 1991;19:942-9.
27. Tryba M. Prophylaxis of stress ulcer bleeding: a meta-analysis. J Clin Gastroenterol 1991;13(suppl 2):44-53.
28. Cook DJ, Laire LA, Guyatt GH, Raffin TA. Nosocomial pneumonia and the role of gastric pH: a meta-analysis. Chest 1991;100:7-13.
29. Tryba M, Cook DJ. Gastric alkalinization, pneumonia, and systemic infections: the controversy. Scand J Gastroenterol 1995;210(suppl):53-9.
30. Cook DJ. Stress ulcer prophylaxis: gastrointestinal bleeding and nosocomial pneumonia: best evidence synthesis. Scand J Gastroenterol 1995;210(suppl):48-52.
31. Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylaxis in critically ill patients: resolving discordant meta-analyses. JAMA 1996;275:306-14.
32. LeLorier J, Benhaddad A, Lapierre J, Derderian F. Discrepancies between meta-analyses and subsequent large, randomized, controlled trials. N Engl J Med 1997;337:536-42.
33. Tryba M. Risk of acute stress bleeding and nosocomial pneumonia in ventilated intensive care unit patients: sucralfate versus antacids. Am J Med 1987;83(suppl 3B):117-24.
34. Fiddian-Green RG, Baker S. Nosocomial pneumonia in the critically ill: product of aspiration or translocation? Crit Care Med 1991;19:763-9.
35. Tryba M. Antibacterial activity of sucralfate in human gastric juice. Am J Med 1987;83(suppl 3B):125-9.
36. Bragman SGL, Pankhurst CL, Casewell MW. Activity of sucralfate (sucrose octa-sulphate), an anti-ulcer agent, against opportunistic gram-negative bacilli. J Antimicrob Chemother 1995;36:703-6.
37. Stannard VA, Hutchinson A, Morris DC, et al. Gastric exocrine "failure" in critically ill patients: frequency and associated features. Br Med J 1988;296:155-6.